News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



One therapy to combat three deadly coronaviruses?

By Reuters Staff (Reuters) - The viruses that cause COVID-19, SARS and MERS have common mechanisms that might be promising targets for a treatment that would work against all three, plus future

COVID-19 rare among U.S. dentists: survey

By Reuters Staff (Reuters) - Less than 1% of U.S. dentists have tested positive for COVID-19, even though dental procedures generate aerosols that may contain particles of the new coronavirus,

Pandemic beliefs, behaviors may be gender-based

By Reuters Staff (Reuters) - Women are more likely than men to consider COVID-19 a serious problem and to agree and comply with restrictions like staying home and wearing masks, survey data suggest.

TAVR likely beneficial in low-risk patients with bicuspid valve stenosis

By Marilynn Larkin NEW YORK (Reuters Health) - Low-surgical risk patients with bicuspid aortic valve stenosis experienced favorable 30-day results with transcatheter aortic valve replacement (TAVR) in

Music training tied to improved attention and working memory in kids

By Lisa Rapaport Oct 16 () - (Reuters Health) - Children who regularly practice a musical instrument may have better attention and working memory than kids who don't, data from functional MRI studies

Carpal tunnel decompression surgery has few serious complications

By Lisa Rapaport (Reuters Health) - Carpal tunnel decompression surgery rarely results in serious complications or reoperations, a U.K. study suggests. Researchers examined data on 855,832 carpal

Transgender youth supportive of telehealth for ongoing gender care

By Lisa Rapaport (Reuters Health) - Many transgender youth are open to receiving gender-affirming care via telehealth, and a new study also suggests that this approach may be preferable for ongoing

Median ALS survival extended 44%, to 25.0 months, by experimental drug

By Reuters Staff (Reuters Health) - Additional results from the phase 2 CENTAUR study on patients with amyotrophic lateral sclerosis (ALS) show that the experimental Amylyx Pharmaceuticals drug

Immediate surgery best in pregnant women with complicated appendicitis

By Megan Brooks NEW YORK (Reuters Health) - For pregnant women with complicated appendicitis, immediate surgery yields significantly better maternal and fetal outcomes than medical management,

CVS, Walgreens to administer COVID-19 vaccines to U.S. nursing homes - HHS

By Reuters Staff (Reuters) - The U.S. government has signed agreements with pharmacy chains CVS Health Corp and Walgreens Boot Alliance to administer COVID-19 vaccines to residents of long-term care

'Not fake news:' COVID-19 cases surge in Wisconsin ahead of Trump campaign rally

By Brendan O'Brien and Maria Caspani CHICAGO (Reuters) - Two weeks ago, Mark Schultz was getting ready to go to work at the tavern he owns in the Wisconsin city of Oshkosh when he started to feel

Telemedicine could help rural patients with dementia

By Carolyn Crist NEW YORK (Reuters Health) - Older adults with dementia require ongoing access to healthcare services, and telemedicine could be a good option to bridge that gap during the pandemic,

Two-vaccine regimen yields best antibody response to Ebola

By Will Boggs MD NEW YORK (Reuters Health) - Sequential administration of two different Ebola vaccines spaced several weeks apart yields the best antibody responses, according to an early trial. Dr.

Diagnosing Hodgkin lymphoma in kids requires biopsy, immunohistochemistry: guidelines

By Will Boggs MD NEW YORK (Reuters Health) - The diagnosis of pediatric Hodgkin lymphoma requires an excisional or incisional biopsy and immunohistochemistry (IHC) evaluation, and its management

Invasive features, positive margins tied to worse outcome of precancerous pancreas lesions

By Will Boggs MD NEW YORK (Reuters Health) - Invasive pathology and positive surgical margins are associated with worse outcomes after resection of intraductal papillary mucinous neoplasms (IPMNs) of

Bone health could be impaired 25 years later in extreme preemies

By Scott Baltic NEW YORK (Reuters Health) - Young adults who were born extremely preterm or with extremely low birthweight (EP/ELBW) may have impaired bone health many years later, compared with their

Long-acting HIV injection gets EU panel endorsement

By Reuters Staff (Reuters) - GlaxoSmithKline Plc said an injection of its cabotegravir drug given every two months, in combination with Johnson & Johnson's rilpivirine, was recommended for approval to

NIH tests therapies to help cut hospital stays for COVID-19 patients

By Reuters Staff (Reuters) - The U.S. National Institutes of Health (NIH) has started a late-stage trial to evaluate if immune-modulating therapies from three drugmakers can help reduce the need for

EU medicine agency could approve COVID-19 vaccines early next year - report

By Reuters Staff MILAN (Reuters) - The European Medicines Agency could approve three COVID-19 vaccines early next year, its Executive Director Guido Rasi said on Friday, according to a report by

Pfizer says earliest COVID-19 vaccine application to U.S. regulators would be after election

By Manas Mishra and Michael Erman (Reuters) Pfizer Inc said on Friday it may file for U.S. authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making

Urologists offer more options for treating erectile dysfunction

By Will Boggs MD NEW YORK (Reuters Health) - Urologists and non-urologists differ in their management of men with erectile dysfunction (ED), according to survey data from the U.S. "While oral

Cannabis use tied to increased odds of non-medical opioid use

By Lisa Rapaport (Reuters Health) - Adults with substance use problems may be more likely to misuse opioids on days when they use cannabis, a study in New York suggests. Researchers examined data from

For some, anti-VEFG treatment preserves sight for a lifetime

By Linda Carroll (Reuters Health) - Nearly 20% of those who received anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) retained useful visual acuity over their lifetime, a

Aerosolized surfactant shows promise for newborns with respiratory distress

By Reuters Staff NEW YORK (Reuters Health) - Delivery of aerosolized calfactant, a type of surfactant, reduced the need for intubation for liquid surfactant by nearly 50% in a large randomized

WHO study says remdesivir did not reduce mortality in COVID-19 patients - FT

By Reuters Staff (Reuters) - Gilead Sciences Inc's remdesivir had no substantial effect on COVID-19 patients' chances of survival, a clinical trial by the World Health Organization (WHO) has found,

In U.S. Midwest states, new COVID-19 infections rise to record highs

By Lisa Shumaker and Maria Caspani CHICAGO (Reuters) - Wisconsin and other states in the U.S. Midwest are battling a surge in COVID-19 cases, with new infections and hospitalizations rising to record

Spain adds 13,300 COVID infections, Catalonia to shut bars, eateries

By Reuters Staff MADRID (Reuters) - Spain's cumulative tally of coronavirus infections rose by over 13,300 on Thursday to 921,374 in a slight acceleration from the previous few days, as the region of

France's new COVID-19 cases set new 24-hour record, above 30,000

By Reuters Staff PARIS (Reuters) - French health authorities on Thursday reported the number of new daily coronavirus infections jumped above 30,000 for the first time since the start of the epidemic.

Coronavirus exposure risk on airplanes very low, U.S. defense study finds

By Reuters Staff (Reuters) - The risk of exposure to the coronavirus on flights is very low, a U.S. Department of Defense study released on Thursday found, a positive sign for the airline industry as

Starting in November, U.S. patients will have open access to clinical notes

By Carolyn Crist (Reuters Health) - Starting November 2, new federal rules will allow U.S. patients to view their electronic health records, including notes written by doctors and health care

Blood chloroform levels in late pregnancy tied to higher risk of SGA newborns

By Marilynn Larkin NEW YORK (Reuters Health) - Chloroform (trichloromethane; TCM) exposure in late pregnancy from drinking water and other disinfection byproducts (DBPs) was associated with a higher

XY gonadal dysgenesis unexpectedly identified by direct-to-consumer genetic testing

By Will Boggs MD NEW YORK (Reuters Health) - A 16-year-old female was unexpectedly identified by direct-to-consumer (DTC) genetic testing to have XY gonadal dysgenesis and subsequently diagnosed with

Percutaneous gallstone removal may be an option in high-risk symptomatic patients

By Marilynn Larkin NEW YORK (Reuters Health) - For patients with acute cholecystitis who are not candidates for surgery, cholecystostomy tube insertion followed by percutaneous cholecystolithotomy (

Telemedicine for pain management may save patients' time and money

By Rob Goodier NEW YORK (Reuters Health) - Virtual pain medicine visits, rather than in-person office visits, saved patients an average of more than two hours in driving time and more than $100 in

Icotinib plus radiotherapy ups survival in elderly with esophageal cancer

By David Douglas NEW YORK (Reuters Health) - Icotinib with concurrent radiotherapy (RT) boosts survival and may have other benefits compared to RT alone in elderly patients with unresectable

Sanofi reports positive animal test results for potential COVID-19 vaccine

By Matthias Blamont PARIS (Reuters) - Clinical trials of an experimental vaccine against COVID-19 which is being developed by France's Sanofi and U.S. biotech firm Translate Bio are on track to begin

WHO vaccine drive bedevilled by familiar question: who pays if things go wrong?

By Francesco Guarascio BRUSSELS (Reuters) - Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in

REFILE-Mental health services disrupted during pandemic, as needs grow - WHO

(Adds link to source material for Oct 5 article, at end of story.) By Reuters Staff GENEVA (Reuters) - Services for mentally ill and substance abuse patients have been disrupted worldwide during the

Young women have worse MI outcomes than men of same age

By Linda Carroll (Reuters Health) - Long term mortality is higher in women than in men who have a myocardial infarction (MI) at a young age, a new study finds. The review of data on more than 2,000

Software predicts which patients may need more post-op opioids

By Rob Goodier NEW YORK (Reuters Health) - Three newly tested software models can mine patients' medical records to predict who may be in greater need of opioid pain medication after surgery,

COVID-19 neurological effects may reflect immune response

By Reuters Staff (Reuters) - The new coronavirus might not be having major direct effects on the brain despite neurological issues that have been widely reported, a new paper suggests. Researchers

Common cold antibodies do not protect against COVID-19

By Reuters Staff (Reuters) - Antibodies that recognize and fight off the coronaviruses that cause common colds are not likely to protect against the coronavirus that causes COVID-19, new research

Regeneron's drug becomes first FDA-approved Ebola virus treatment

By Deena Beasley (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals' triple antibody cocktail as the first Ebola treatment, lending validation to similar

Motivational interviews with parents help them support kids' weight management

By Lisa Rapaport (Reuters Health) - Motivational interviews with parents appears to help them promote healthy habits in children, a systematic review suggests. "Some more traditional approaches of

New coronavirus rapid diagnostic tests will be game changer -PAHO director

By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Rapid antigen diagnostic tests for the novel coronavirus will be a game changer in the fight against the pandemic, the Pan American

Curfews and lockdowns as shaken Europe overtakes U.S. in virus surge

By Benoit Van Overstraeten and Jan Lopatka PARIS/PRAGUE (Reuters) - France imposed curfews while other European nations are closing schools, cancelling surgeries and enlisting student medics as

Bariatric surgery increases life expectancy in large Swedish study

By Gene Emery (Reuters Health) - Bariatric surgery gives severely-obese patients an average of three extra years of life, although the operation does not bring the risk of early death down to the same

Upadacitinib superior to abatacept for arthritis but sparks more side effects

By Gene Emery (Reuters Health) - A 24-week phase 3 trial of AbbVie's upadacitinib shows that it produces more remissions and a better score on a rheumatoid arthritis (RA) scale than conventional

Hospitalized US children often exposed to drug-drug interactions

By Lisa Rapaport (Reuters Health) - Proportions of hospitalized U.S. children who are exposed to potentially serious drug-drug interactions vary widely, and the risk is increased with longer stays and

Double-targeted CAR-T cell immunotherapy promising for refractory non-Hodgkin lymphoma

By Marilynn Larkin NEW YORK (Reuters Health) - A novel chimeric antigen receptor (CAR)-T cell therapy for refractory B-cell non-Hodgkin lymphoma that targets both CD19 and CD20 antigens was safe and

'STOP THE BLEED' saving lives across the globe

By Megan Brooks NEW YORK (Reuters Health) - The American College of Surgeons (ACS) STOP THE BLEED training program is saving lives around the world, according to two studies presented October 3 at the

SARS-CoV-2 worsens outcomes in cancer patients

By Will Boggs MD NEW YORK (Reuters Health) - Outcomes are worse in patients with cancer who test positive for SARS-CoV-2 than in those who test negative, according to a study of US Veterans Affairs

Fewer complications with transcarotid revascularization vs endarterectomy

By Will Boggs MD NEW YORK (Reuters Health) - Transcarotid revascularization (TCAR) with dynamic flow reversal is associated with fewer complications, but similar rates of stroke or death, than

Thiopurine alone maintains remission in more than half of UC patients

By Anne Harding NEW YORK (Reuters Health) - Thiopurine monotherapy is an effective, durable treatment for ulcerative colitis (UC), but it is less likely to be effective in patients with Crohn's

Eli Lilly to continue other COVID-19 antibody drug trials after pausing one on safety concerns

By Carl O'Donnell and Michael Erman (Reuters) - Eli Lilly & Co on Wednesday said that other trials of its experimental COVID-19 antibody drug bamlanivimab will continue apace after it paused one

Countries turn to rapid antigen tests to contain second wave of COVID-19

By John Miller, Caroline Copley and Bart H. Meijer ZURICH/BERLIN (Reuters) - Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid

Sex, age among predictors of ongoing pain after laparoscopic inguinal-hernia repair

By David Douglas NEW YORK (Reuters Health) - About one in 17 patients experience chronic pain following laparoscopic inguinal hernia repair (LIHR), and those at higher risk include women and younger

Genetic expression varies with cortical structure, brain region

By Reuters Staff NEW YORK (Reuters Health) - A study in healthy adults implicates dozens of genes in shrinkage of the cortex, the layer of the brain that gives rise to thinking, awareness and action.

Sanitising-gel poisoning cases soar among Spanish children amid pandemic

By Reuters Staff MADRID (Reuters) - The number of Spanish children treated for poisoning after ingesting hand-sanitising gels has rocketed as the product has become ubiquitous during the coronavirus

YouTube bans coronavirus vaccine misinformation

By Elizabeth Culliford and Paresh Dave (Reuters) - Alphabet Inc's YouTube said on Wednesday it would remove videos from YouTube containing misinformation about COVID-19 vaccines, expanding its current

Pandemic puts global progress against tuberculosis at risk - WHO

By Reuters Staff LONDON (Reuters) - The COVID-19 pandemic is derailing global efforts to tackle tuberculosis (TB), the world's deadliest infectious disease, with cases likely to rise without urgent

Air cargo industry not yet ready for COVID-19 vaccine distribution- survey

By Jamie Freed SYDNEY, Oct 14 (Reuters) - Only 28% of participants in the air cargo industry feel they are well prepared to distribute a COVID-19 vaccine once available, according to a survey released

Putin says Russia approves second COVID-19 vaccine

By Reuters Staff MOSCOW (Reuters) - Russia has granted regulatory approval to a second COVID-19 vaccine, a delighted President Vladimir Putin announced at a government meeting on Wednesday. Putin

'On brink of disaster': shaken Europe battles COVID surge

By Jan Lopatka and Marine Strauss PRAGUE/BRUSSELS (Reuters) - European nations are extending restrictions well beyond social life to close schools, cancel surgeries and enlist legions of student

Exercise intensity not linked to mortality risk in older adults

By Linda Carroll (Reuters Health) - Harder workouts won't cut older lives short, a new study finds. In an analysis of data from more than 1,500 seniors randomly assigned to moderate or intense

J&J to contribute up to $5 billion to potential U.S. opioid settlement

By Nate Raymond (Reuters) - Johnson & Johnson said on Tuesday it will contribute up to $1 billion more to a potential settlement of lawsuits alleging it and other companies fueled the U.S. opioid

U.S. govt signs deal to make more COVID-19 vaccine components

By Reuters Staff (Reuters) - The U.S. government has entered an agreement with life sciences company Cytiva, a unit of Danaher Corp to expand the manufacturing of products needed to make COVID-19

Belfast hospitals cancel elective surgeries as COVID-19 swirls

By Amanda Ferguson BELFAST (Reuters) - Elective surgeries have been cancelled across Belfast this week due to a rise in COVID-19 admissions, the Northern Ireland body that runs the city's hospitals

Cue Health awarded $481 mln to scale up production of COVID-19 test -HHS

By Reuters Staff (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of

COVID-19 antigen test better at identifying who is still infectious

By Reuters Staff (Reuters) - Becton Dickenson and Co's BD Veritor System for rapid detection of the novel coronavirus is better than gold standard real-time polymerase chain reaction (RT-PCR) lab

Asthma patients appear less likely to die from COVID-19

By Reuters Staff (Reuters) - Patients with asthma who become infected with the new coronavirus appear to have no higher risk of hospitalization or need for mechanical breathing assistance compared to

Lyme neuroborreliosis does not seem to boost psychiatric risk

By Marilynn Larkin NEW YORK (Reuters Health) - Lyme neuroborreliosis was not associated with a higher risk of developing psychiatric disease requiring hospitalization or prescription medication in a

Newborn screening for inherited metabolic diseases has long-term benefits

By Reuters Staff NEW YORK (Reuters Health) - A new study shows that newborn screening (NBS) for inherited metabolic diseases has long-term benefits for affected individuals, "thus proving the success

Virtual trauma-focused therapy may aid veterans, others with PTSD

By Lisa Rapaport (Reuters Health) - Military members, veterans, police, firefighters and other public safety personnel suffering from post-traumatic stress disorder (PTSD) may benefit from virtual

Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern

By Michael Erman and Carl O'Donnell (Reuters) - Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President

Textured implants linked to increased breast cancer recurrence risk

By Reuters Staff NEW YORK (Reuters Health) - Using textured implants for reconstruction after mastectomy is associated with greater risk of breast cancer recurrence compared to smooth implants,

Mexico aims to vaccinate 116 million against coronavirus by end of 2021

By Reuters Staff MEXICO CITY, Oct 13 (Reuters) - Mexico plans to vaccinate more than 116 million people, or roughly 90% of its population, against the novel coronavirus by the end of 2021 after

EXCLUSIVE-FDA faults quality control at Lilly plant making Trump-touted COVID drug

By Dan Levine and Marisa Taylor (Reuters) - U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly and Co pharmaceutical plant that is ramping up to manufacture one of two

Palliative care reduces health care use, symptom burden in chronic noncancer illness

By Will Boggs MD NEW YORK (Reuters Health) - Palliative care interventions are associated with reduced health care use and modestly lower symptom burden, but not with improved quality of life, in

Lopinavir-ritonavir does not improve COVID-19 outcomes

By Will Boggs MD NEW YORK (Reuters Health) - Lopinavir-ritonavir is not associated with improved outcomes in patients hospitalized with COVID-19, a new trial shows. Dr. Peter W. Horby from the

Durability of newer TAVR valve comparable to that with SAVR

By David Douglas NEW YORK (Reuters Health) - Following transcatheter aortic valve replacement (TAVR) using a 3rd generation device, structural valve deterioration (SVD) does not differ markedly from

U.S. prescription opioid abuse was declining before pandemic

By Rob Goodier NEW YORK (Reuters Health) - Prescription opioid abuse in the United States declined dramatically from 2009 to 2018, raw data indicate. Weighted data also showed a statistically

Facebook will ban ads discouraging people from getting vaccines

By Elizabeth Culliford (Reuters) - Facebook Inc will start banning ads that explicitly discourage people from getting vaccinated, the world's largest social media company said on Tuesday, as it also

NIH starts clinical trial testing antibody drugs in COVID-19 patients

By Reuters Staff (Reuters) - The U.S. National Institutes of Health (NIH) said on Tuesday it has started a study to evaluate two monoclonal antibody drugs in hospitalized COVID-19 patients as part of

COVID-19 again? Reinfection cases raise concerns over immunity

By Kate Kelland LONDON (Reuters) - The case of a man in the United States infected twice with COVID-19 shows there is much yet to learn about immune responses and also raises questions over

J&J says review of illness that led to pause of coronavirus vaccine trial could take days

By Reuters Staff (Reuters) - Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company's late-stage COVID-19 vaccine

COVID-19 antibodies last at least three months

By Reuters Staff (Reuters) - People infected with COVID-19 develop antibodies targeting the new coronavirus that last for at least three months, according to two reports in Science Immunology. The two

COVID-19 symptoms linger for months for many

By Reuters Staff (Reuters) - Three months after becoming ill, many COVID-19 patients still have symptoms, two studies confirm, and the more severe the initial infections, the higher the odds of

Endoscopic sleeve gastroplasty likely safe, effective for obesity over 5 years

By Marilynn Larkin NEW YORK (Reuters Health) - Endoscopic sleeve gastroplasty (ESG) was safe and effective for weight loss, during a single-center five-year follow-up study. "It is a great procedure,

Colonoscopy patients often get surprise out-of-network bills

By Linda Carroll (Reuters Health) - Surprise out-of-network bills greet nearly one in eight patients who get a colonoscopy in the U.S., a new study finds. An analysis of a large national insurer's

Endoscopic duodenal resurfacing may eliminate need for insulin in type-2 diabetes

By Megan Brooks NEW YORK (Reuters Health) - A single endoscopic duodenal mucosal resurfacing (DMR), coupled with a GLP-1 receptor agonist and lifestyle coaching, can eliminate the need for insulin in

Hep B liver cancer risk comparable with tenofovir, entecavir

By Marilynn Larkin NEW YORK (Reuters Health) - Chronic hepatitis B patients face similar risk liver cancer risks whether treated with tenofovir or entecavir, according to a systematic review and

Perforated appendicitis in kids more common after COVID-19 outbreak

By Will Boggs MD NEW YORK (Reuters Health) - The rates of perforated appendicitis in children in the New York City metropolitan region increased after the beginning of the COVID-19 pandemic,

Number of COVID patients in French intensive care units highest in nearly 5 months

By Reuters Staff PARIS (Reuters) - The number of people being treated in French intensive care units for COVID-19 exceeded 1,500 on Monday for the first time since May 27, authorities said, raising

Calcium-channel abnormalities underlie genetic cause of schizophrenia

By Will Boggs MD NEW YORK (Reuters Health) - In 22q11.2 deletion syndrome, a common genetic cause of schizophrenia, abnormalities in calcium-channel signaling resulting from the loss of the gene DGCR8

Perinatally HIV-infected adolescents have impaired bone health

By Will Boggs MD NEW YORK (Reuters Health) - Perinatally HIV-infected adolescents have impaired bone health, research from South Africa confirms. Some previous studies have reported adverse bone

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information